BlackRock’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
2019
Q4
$9K Sell
2019
Q3
$633K Sell
2019
Q2
$1.11M Sell
2019
Q1
$1.71M Sell
2018
Q4
$2.01M Buy
2018
Q3
$9.58M Buy
2018
Q2
$10.5M Buy
2018
Q1
$6.34M Buy
2017
Q4
$9.55M Buy